TLC+ (Testing and Linkage to Care Plus Treatment):
In December 2009, a multi-disciplinary group of experts met to consider whether implementing a Test & Treat strategy could help the US accomplish three important goals: 1) increase the percentage of HIV-positive Americans who know their serostatus, 2) improve the health outcomes of individuals who are HIV-positive, and 3) reduce HIV incidence.
The Think Tank, initiated by Project Inform,Â resulted in a recommendation to establish a national program called “Testing & Linkage to Care Plus” or “TLC+” (the “+” referring to Treatment) as an element of the upcoming National HIV/AIDS Strategy. Now that it’s has been incorporated into the Strategy, we are exploring ways to utilize a TLC+ strategy and how to best implement it. We convene a national TLC+ Working Group to identify emerging issues and develop strategy around implementation of TLC+.
RESOURCESÂ ON TLC+
Best Practices to Implement Enhanced TLC+ in Four Cities
Treatment as Prevention
It has now been proven that individuals who are effectively treated for HIV can be as much as 96% less likely to transmit the virus to sexual partners.Â This fact has motivated Project Inform’s advocacy for expanded HIV treatment as an important Â form of prevention. We have prepared a fact sheet that describes the role of treatment as prevention.Â We also helped give rise to a Declaration that the data proving that treatment is prevention now make it possible for the world to end HIV/AIDS, if governments and funders seize the opportunity. You can add your name as a signer of this Declaration. Sign declaration to end AIDS!
PrEP (Pre-exposure prevention):
PrEP refers to using a product, like a pill or microbicide, that contains HIV medicines to prevent infection in a HIV-negative person. Currently, more than 10 clinical studies are assessing the safety and effectiveness of PrEP in sites all over the world. Project Inform is monitoring these studies and other research in order to determine how best to proceed with PrEP implementation. We have written a policy paper describing Â general issues in PrEP implementation, a policy paper describing how PrEP might be financed, and are currently advocating for demonstration projects to assess the feasibility and effectiveness of PrEP outside of clinical studies.
For more information, go to PrEP Resources page.